1COV Fundamental Analysis - COVESTRO AG

Fundamental Rating

1COV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 72 industry peers in the Chemicals industry. Both the profitability and financial health of 1COV have multiple concerns. 1COV is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

1COV had negative earnings in the past year.

In the past year 1COV had a positive cash flow from operations.

In multiple years 1COV reported negative net income over the last 5 years.

1COV had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

1COV has a worse Return On Assets (-3.46%) than 76.39% of its industry peers.

1COV's Return On Equity of -7.52% is on the low side compared to the rest of the industry. 1COV is outperformed by 77.78% of its industry peers.

		Industry Rank	Sector Rank
ROA	-3.46%
ROE	-7.52%
ROIC	N/A

ROA(3y)-1.76%

ROA(5y)1.73%

ROE(3y)-3.61%

ROE(5y)3.67%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

In the last couple of years the Operating Margin of 1COV has declined.

1COV's Gross Margin of 13.93% is on the low side compared to the rest of the industry. 1COV is outperformed by 79.17% of its industry peers.

In the last couple of years the Gross Margin of 1COV has declined.

The Profit Margin and Operating Margin are not available for 1COV so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	13.93%

OM growth 3Y-78.51%

OM growth 5Y-54.06%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-18%

GM growth 5Y-7.1%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

1COV does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for 1COV remains at a similar level compared to 1 year ago.

1COV has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, 1COV has an improved debt to assets ratio.

2.2 Solvency

1COV has an Altman-Z score of 2.26. This is not the best score and indicates that 1COV is in the grey zone with still only limited risk for bankruptcy at the moment.

With a Altman-Z score value of 2.26, 1COV perfoms like the industry average, outperforming 47.22% of the companies in the same industry.

A Debt/Equity ratio of 0.34 indicates that 1COV is not too dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.34, 1COV is in line with its industry, outperforming 59.72% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.34
Debt/FCF	N/A
Altman-Z	2.26

ROIC/WACCN/A

WACC6.33%

2.3 Liquidity

1COV has a Current Ratio of 1.36. This is a normal value and indicates that 1COV is financially healthy and should not expect problems in meeting its short term obligations.

With a Current ratio value of 1.36, 1COV is not doing good in the industry: 75.00% of the companies in the same industry are doing better.

1COV has a Quick Ratio of 1.36. This is a bad value and indicates that 1COV is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Quick ratio value of 0.73, 1COV is not doing good in the industry: 76.39% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	1.36
Quick Ratio	0.73

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

1COV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -76.09%.

1COV shows a decrease in Revenue. In the last year, the revenue decreased by -5.27%.

The Revenue has been growing slightly by 2.70% on average over the past years.

EPS 1Y (TTM)-76.09%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-247.06%

Revenue 1Y (TTM)-5.27%

Revenue growth 3Y-3.75%

Revenue growth 5Y2.7%

Sales Q2Q%-11.99%

3.2 Future

The Earnings Per Share is expected to grow by 20.37% on average over the next years. This is a very strong growth

1COV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.10% yearly.

EPS Next Y-32.24%

EPS Next 2Y53.57%

EPS Next 3Y43.92%

EPS Next 5Y20.37%

Revenue Next Year-7.37%

Revenue Next 2Y-2.5%

Revenue Next 3Y-0.41%

Revenue Next 5Y1.1%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

1COV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Based on the Price/Forward Earnings ratio of 116.82, the valuation of 1COV can be described as expensive.

Based on the Price/Forward Earnings ratio, 1COV is valued a bit more expensive than 73.61% of the companies in the same industry.

The average S&P500 Price/Forward Earnings ratio is at 23.56. 1COV is valued rather expensively when compared to this.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	116.82

4.2 Price Multiples

1COV's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 1COV is more expensive than 69.44% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	16.89

4.3 Compensation for Growth

1COV's earnings are expected to grow with 43.92% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y53.57%

EPS Next 3Y43.92%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

1COV does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

COVESTRO AG

FRA:1COV (12/9/2025, 5:26:41 PM)

59.46

-0.04 (-0.07%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)10-30 2025-10-30/bmo

Earnings (Next)02-26 2026-02-26/amc

Inst Owners23.42%

Inst Owner ChangeN/A

Ins Owners0.03%

Ins Owner ChangeN/A

Market Cap11.24B

Revenue(TTM)13.40B

Net Income(TTM)-458.00M

Analysts49.47

Price Target62.02 (4.31%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0.01

Dividend Growth(5Y)-70.61%

DP-0.22%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-69.67%

Min EPS beat(2)-139.31%

Max EPS beat(2)-0.04%

EPS beat(4)0

Avg EPS beat(4)-380.46%

Min EPS beat(4)-1222.75%

Max EPS beat(4)-0.04%

EPS beat(8)1

Avg EPS beat(8)-4244%

EPS beat(12)2

Avg EPS beat(12)-2876.36%

EPS beat(16)3

Avg EPS beat(16)-2162.14%

Revenue beat(2)0

Avg Revenue beat(2)-4.63%

Min Revenue beat(2)-6.91%

Max Revenue beat(2)-2.34%

Revenue beat(4)0

Avg Revenue beat(4)-4.71%

Min Revenue beat(4)-6.91%

Max Revenue beat(4)-2.34%

Revenue beat(8)0

Avg Revenue beat(8)-4.43%

Revenue beat(12)0

Avg Revenue beat(12)-4.49%

Revenue beat(16)3

Avg Revenue beat(16)-2.5%

PT rev (1m)0.26%

PT rev (3m)-1.14%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-13.02%

EPS NY rev (1m)0%

EPS NY rev (3m)-62.78%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-8.71%

Revenue NY rev (1m)0.11%

Revenue NY rev (3m)-5.13%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	116.82
P/S	0.84
P/FCF	N/A
P/OCF	14.08
P/B	1.85
P/tB	2.27
EV/EBITDA	16.89

EPS(TTM)-2.43

EYN/A

EPS(NY)0.51

Fwd EY0.86%

FCF(TTM)-0.62

FCFYN/A

OCF(TTM)4.22

OCFY7.1%

SpS70.92

BVpS32.22

TBVpS26.24

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-3.46%
ROE	-7.52%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	13.93%
FCFM	N/A

ROA(3y)-1.76%

ROA(5y)1.73%

ROE(3y)-3.61%

ROE(5y)3.67%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)1.42%

ROCE(5y)6.03%

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y-78.51%

OM growth 5Y-54.06%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-18%

GM growth 5Y-7.1%

F-Score3

Asset Turnover1.01

Health

		Industry Rank	Sector Rank
Debt/Equity	0.34
Debt/FCF	N/A
Debt/EBITDA	2.47
Cap/Depr	92.05%
Cap/Sales	6.83%
Interest Coverage	N/A
Cash Conversion	95%
Profit Quality	N/A
Current Ratio	1.36
Quick Ratio	0.73
Altman-Z	2.26

F-Score3

WACC6.33%

ROIC/WACCN/A

Cap/Depr(3y)75.52%

Cap/Depr(5y)82.02%

Cap/Sales(3y)5.15%

Cap/Sales(5y)5.37%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-76.09%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-247.06%

EPS Next Y-32.24%

EPS Next 2Y53.57%

EPS Next 3Y43.92%

EPS Next 5Y20.37%

Revenue 1Y (TTM)-5.27%

Revenue growth 3Y-3.75%

Revenue growth 5Y2.7%

Sales Q2Q%-11.99%

Revenue Next Year-7.37%

Revenue Next 2Y-2.5%

Revenue Next 3Y-0.41%

Revenue Next 5Y1.1%

EBIT growth 1Y-220.31%

EBIT growth 3Y-79.32%

EBIT growth 5Y-52.83%

EBIT Next Year238.79%

EBIT Next 3Y78.95%

EBIT Next 5Y42.34%

FCF growth 1Y-116.5%

FCF growth 3Y-60.36%

FCF growth 5Y-28.37%

OCF growth 1Y-45.3%

OCF growth 3Y-26.52%

OCF growth 5Y-8.84%

COVESTRO AG / 1COV.DE FAQ

What is the fundamental rating for 1COV stock?

ChartMill assigns a fundamental rating of 2 / 10 to 1COV.DE.

What is the valuation status of COVESTRO AG (1COV.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to COVESTRO AG (1COV.DE). This can be considered as Overvalued.

Can you provide the profitability details for COVESTRO AG?

COVESTRO AG (1COV.DE) has a profitability rating of 1 / 10.

How financially healthy is COVESTRO AG?

The financial health rating of COVESTRO AG (1COV.DE) is 3 / 10.

COVESTRO AG (1COV.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

COVESTRO AG / 1COV.DE FAQ

What is the fundamental rating for 1COV stock?

What is the valuation status of COVESTRO AG (1COV.DE) stock?

Can you provide the profitability details for COVESTRO AG?

How financially healthy is COVESTRO AG?